Cannara Biotech Reports Q3 Results
Cannara Biotech reported mixed results in its third-quarter financial performance, with a slight increase in gross cannabis revenue and net revenue year-over-year but significant declines in earnings per share (EPS) and operating income. The company's adjusted EBITDA also decreased by 15% compared to the prior year.
Topics: financials profitability revenue